1 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66 (2): 115-132.
|
2 |
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2017, 28 (suppl 4): iv22-iv40.
|
3 |
Bosset JF, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study[J]. Lancet Oncol, 2014, 15 (2): 184-190.
|
4 |
Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients[J]. Int J Radiat Oncol Biol Phys, 2008, 72 (1): 99-107.
|
5 |
Rau B, Wust P, Tilly W, et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters[J]. Int J Radiat Oncol Biol Phys, 2000, 48 (2): 381-391.
|
6 |
Gani C, Lamprecht U, Ziegler A, et al. Deep region-al hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase Ⅱ trial[J]. Radiother Oncol, 2021 (159): 155-160.
|
7 |
Zwirner K, Bonomo P, Lamprecht U, et al. External validation of a rectal cancer outcome prediction model with a cohort of patients treated with preoperative radiochemotherapy and deep regional hyperthermia[J]. Int J Hyperthermia, 2018, 34 (4): 455-460.
|
8 |
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer-Verlag, 2009: 117-126.
|
9 |
Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment[J]. Semin Radiat Oncol, 2003, 13 (3): 176-181.
|
10 |
Rau B, Wust P, Hohenberger P, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase Ⅱ clinical trial[J]. Ann Surg, 1998, 227 (3): 380-389.
|
11 |
Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2018, 16 (7): 874-901.
|
12 |
Lee WS, Baek JH, Shin DB, et al. Neoadjuvant treatment of mid-to-lower rectal cancer with oxaliplatin plus 5-fluorouracil and leucovorin in combination with radiotherapy: a Korean single center phase Ⅱ study[J]. Int J Clin Oncol, 2013, 18 (2): 260-266.
|
13 |
Li Y, Wang J, Ma X, et al. A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer[J]. Int J Bio Sci, 2016, 12 (8): 1022-1031.
|
14 |
Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer[J]. J Clin Oncol, 2015, 33 (16): 1797-1808.
|
15 |
Minsky BD, Cohen AM, Kemeny N, et al. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable recta cancer[J]. Int J Radiat Oncol Biol Phys, 1993, 25 (5): 821-827.
|
16 |
Arjona-Sánchez A, Barrios P, Boldo-Roda E, et al. HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma[J]. BMC Cancer, 2018, 18 (1): 183.
|
17 |
Shoji H, Motegi M, Osawa K, et al. A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study[J]. Cancer Med, 2015, 4 (6): 834-843.
|
18 |
Kang MK, Kim MS, Kim JH. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy[J]. Int J Hyperthermia, 2011, 27 (5): 482-490.
|
19 |
Maluta S, Romano M, Dall'oglio S, et al. Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum[J]. Int J Hyperthermia, 2010, 26 (2): 108-117.
|
20 |
Tsutsumi S, Tabe Y, Fujii T, et al. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy[J]. Anticancer Res, 2011, 31 (11): 3963-3967.
|
21 |
van der Zee J, González González D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group[J]. Lancet, 2000, 355 (9210): 1119-1125.
|
22 |
van der Valk MJM, Marijnen CAM, van Etten B, et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer-results of the international randomized RAPIDO-trial[J]. Radiother Oncol, 2020 (147): 75-83.
|
23 |
Asao T, Sakurai H, Harashima K, et al. The synchronization of chemotherapy to circadian rhythms and irradiation in pre-operative chemoradiation therapy with hyperthermia for local advanced rectal cancer[J]. Int J Hyperthermia, 2006, 22 (5): 399-406.
|